Bridging the Access Gap: Eli Lilly, Wieden+Kennedy, and the New Era of Medicare GLP-1 Coverage
Executive Overview The landscape of obesity treatment and public health policy in the United States underwent a subtle yet profound shift last week with the public debut of “A Life…